A propos de Syncrosome –

Partner of large and medium drug discovery companies all around the world since 2000, as a preclinical contract research, our main activities consist in :

DRUG EFFICACY STUDIES BIOAVAILABILITY AND CNS-PK STUDIES.

We have developed and validated so far more than 15 disease models; our flexible and human-sized organization can design and operate tailored experimental protocols to give you appropriate answers.

Beyond sound science, our proactive approach combining pharmacological expertise, appropriate study design, relevant endpoints performed on relevant and complementary disease models, provide our clients with the most relevant data.

Besides our premium services and track record of success, we pay a special attention to ethics, animal welfare, sustainable development and the validation of up to date techniques.